Elanix Biotechnologies' PIPE Round

Elanix Biotechnologies raised a round of funding on April 30, 2018. Investors include Yorkville Advisors.

Elanix Biotechnologies Ltd. (Frankfurt: ELN) develops and commercializes tissue regeneration products for acute wound care, dermatological and gynecological applications, and provides services in cell…

Articles about Elanix Biotechnologies' PIPE Round: